Cost-effectiveness analysis of domestic 13-valent pneumococcal conjugate vaccine for children under 5 years of age in mainland China

References

• Shiri T, Khan K, Keaney K, Mukherjee G, McCarthy ND, Petrou S. Pneumococcal disease: Asystematic review of health utilities, resource use, costs, and economic evaluations of interventions. Value Health. 2019;22(11):1329–44. doi:10.1016/j.jval.2019.06.011.
   PubMed Web of Science ®Google Scholar
• Brian W, O’Brien KL, Adena G, Majumder A, Liu L, Chu Y, Lukšić I, Nair H, McAllister DA, Campbell H, etal. Burden of Streptococcus pneumoniae and Haemophilus influenzae type bdisease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000–15. Lancet Global Health. 2018;6(7):e744–e757. doi:10.1016/S2214-109X(18)30247-X.
   PubMed Web of Science ®Google Scholar
• Song JH. Advances in pneumococcal antibiotic resistance. Expert Rev Respir Med. 2013;7(5):491–98. doi:10.1586/17476348.2013.816572.
   PubMed Web of Science ®Google Scholar
• Lewnard JA, Lo NC, Arinaminpathy N, Frost I, Laxminarayan R. Childhood vaccines and antibiotic use in low- and middle-income countries. Nature. 2020;581(7806):94–99. doi:10.1038/s41586-020-2238-4.
   PubMed Web of Science ®Google Scholar
• WHO. Pneumococcal conjugate vaccines in infants and children under 5 years of age: WHO position paper– february 2019.
   Google Scholar
• World Health Organization. Immunization coverage: 2019,[accessed, Sep 15, 2020].  https://www.who.int/news-room/fact-sheets/detail/immunization-coverage
   Google Scholar
• Choi MJ, Kang SO, Oh JJ, Park S-B, Kim M-J, Cheong H-J. Cost-effectiveness analysis of 13-valent pneumococcal conjugate vaccine versus 23-valent pneumococcal polysaccharide vaccine in an adult population in South Korea. Hum Vaccin Immunother. 2018;14(8):1914–22. doi:10.1080/21645515.2018.1456602.
   PubMed Web of Science ®Google Scholar
• Hua Z, Jinchun H, Bin W, Che D. Cost-effectiveness analysis of routine 13-valent pneumococcal conjugate vaccinations in Chinese infants. Hum Vaccin Immunother. 2018;14(6):1444–52. doi:10.1080/21645515.2018.1438794.
   Google Scholar
• Lizhi L, Lixia Y, Yi C, Ting F, Liang Z, Hongjun D, Guozhang X. Vaccination coverage of 13-valent pneumococcal conjugate vaccine among children born in 2017-2018 in Ningbo City, Zhejiang Province, China. Clin JBiol. 2020;33(1):50–54.
   Google Scholar
• ShenK, Wasserman M, Liu D, YangHong Y, Yang J, Guzauskas GF, Wang BCM, Hilton B, Farkouh R. Estimating the cost-effectiveness of an infant 13-valent pneumococcal conjugate vaccine national immunization program in China. PLoS One. 2018;13(7):e0201245. doi:10.1371/journal.pone.0201245
   Google Scholar
• Maurer KA, Huey-Fe C, Abram LW, Hegde ST, Patel T, Boulton ML, Hutton DW. Cost-effectiveness analysis of pneumococcal vaccination for infants in China. Vaccine. 2016;34(50):6343–49. doi:10.1016/j.vaccine.2016.10.051.
   Google Scholar
• Jingjing C, Lin Y, Zhen H, Shi NM, Zhao YL, Xia SL, Li GH, Li RC, Li YP, Yang SY, et al. Safety and immunogenicity of anew 13-valent pneumococcal conjugate vaccine versus alicensed 7-valent pneumococcal conjugate vaccine: astudy protocol of arandomized non-inferiority trial in China. BMJOpen. 2016;6(10):e012488. doi:10.1136/bmjopen-2016-012488.
   Google Scholar
• Guijun N, Xuxia W, Shiwen L, Yuying Z, Bingling Z, Xiaoshu Z, Yixing L, Zhundong Y, Weizhong Y. Retrospective investigation of the disease burden of community acquired pneumonia among children under 5 years old in Baiyin city of Gansu province, 2015-2016. Chin jvacc immun. 2017;23(1):18–21+12.
   Google Scholar
• Yixing L, Zhujun S, Huanyu W, Guijun N, Junhong L, Zhundong Y. Acute meningitis and encephalitis syndrome surveillance disease burden in four China prefectures. Chin JPrevent Med. 2019;53(2):164–68.
   Google Scholar
• Investigation of Pre-school Chidren’s Secretory Otitis Media Prevalence in Xiantao City. JAudiol Speech Pathol. 2015;23:12–314.
   Google Scholar
• JunL. Prevalence of secretory otitis media in some kindergarten children in Tanggu District. Harbin Med. 2013;33:194–200
   Google Scholar
• Zhinan W, Ping C, Zhongqiang X, Youhua W, Yanling H, Bin Z, Ronghua H, Zhong C,Sunfang Y. The prevalence of otitis media with effusion of kindergarten children in Wuhan city. JClin Otolaryngol Head Neck Surgery. 2009;23(22):1036–1037+1043.
   Google Scholar
• Yibing D, Meiling W. Recent Investigation on the Occurrence of Ophthalmitis and Otitis media in Preschool Children. Mater Child Health Care China. 2004;7(2):119.
   Google Scholar
• Hongyan T, Ruidan H, Qing L. Investigation on the prevalence of secretory otitis media in children aged 2–7 in Chengdu. JAudiol Speech Pathol. 2019;27:83–84.
   Google Scholar
• National Bureau of Statistics of China. China Statistical Yearbooks. Beijing: 2019 [accessed Sep 15, 2019]. http://www.stats.gov.cn/tjsj/ndsj/2019/indexch.htm.
   Google Scholar
• Wenting L. Study on economic burden of bacterial meningitis in China[dissertation]. Beijing: Chinese Center for Disease Control and Prevention; 2016.
   Google Scholar
• Guijun N, Zundong Y, Yixing L, Qinghua W, Wenzhong Y. Cost-effectiveness of the Haemophilus influenzae type bvaccine for infants in mainland China. Hum Vaccin Immunother. 2018;14(1):36–44. doi:10.1080/21645515.2017.1385687.
   Google Scholar
• Huanzhong X, Changwei Q. Educational statistics yearbook of China. 2015. Beijing: China Statistics Press; 2016.
   Google Scholar
• Guijun N, Xuxia W, Dan W, Yin Z, Li Y, Wang H, Yang W. The etiology of community-acquired pneumonia among children under 5 years of age in mainland China, 2001-2015: Asystematic review. Hum Vaccin Immunother. 2017;13(1):2742–50. doi:10.1080/21645515.2017.1371381.
   Google Scholar
• Jinjian F, Ling L, Zhuoxin L, Xu S, Lin N, Qin P, Ye X, McGrath E. Etiology of acute otitis media and phenotypic-molecular characterization of streptococcus pneumoniae isolated from children in Liuzhou, China. BMC Infect Dis. 2019;19(1):168. doi:10.1186/s12879-019-3795-8.
   Google Scholar
• Oostenbrink R, Ha AM, Essink-Bot ML. The EQ-5D and the Health Utilities Index for permanent sequelae after meningitis: A head-to-head comparison. JClin Epidemiol. 2002;55(8):791–99. doi:10.1016/S0895-4356(02)00448-1.
   Google Scholar
• Oh PI, Maerov P, Pritchard D, Knowles SR, Einarson TR, Shear NH. A cost-utility analysis of second-line antibiotics in the treatment of acute otitis media in children. Clin Ther. 1996;18(1):160-82. doi: 10.1016/s0149-2918(96)80188-3.
   Google Scholar
• Bennett JE, Sumner W, Downs SM, Jaffe DM. Parents’ utilities for outcomes of occult bacteremia. Arch Pediatr Adolesc Med. 2000;154:43–48.
   Google Scholar
• Delgleize E, Leeuwenkamp O, Theodorou E, Van de Velde N. Cost-effectiveness analysis of routine pneumococcal vaccination in the UK: acomparison of the PHiD-CV vaccine and the PCV-13 vaccine using a Markov model. BMJ Open. 2016;6(11):e010776. doi:10.1136/bmjopen-2015-010776.
   Google Scholar
• Marie RG, Yuwei Z, Matthew RM, Cynthia GW, Carlos GG. U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination. N Engl J Med. 2013;369(2):155-63. doi:10.1056/NEJMoa1209165.
   Google Scholar
• Machao L, Yao W, Hong Z, Yong L, XueJun C, HongWei Y, Ping M, DingCheng W, Bingchang Z, Aiying D, et al. Serotype distribution and clinical characteristics associated with streptococcus pneumoniae among Chinese children and adults with invasive pneumococcal disease: a multicenter observational study. Hum Vaccin Immunother. [Preprint.] 2020 [accessed, Jan 4, 2021]. doi: 10.1080/21645515.2020.1757996.
   Google Scholar
• Wang J, Liu F, Ao P, Li X, Zheng H, Wu D, Zhang N, Yu J, Yuan J, Wu X, et al. Detection of Serotype Distribution and Drug Resistance of Streptococcus Pneumoniae Isolated From Pediatric Patients. Lab Med. 2017;48(1):39–45. doi:10.1093/labmed/lmw059
   Google Scholar
• Hu Y, Chen Y, Liang H, Wang Y. Routine vaccination coverage of children aged 1-7 years in Zhejiang province, China. Hum Vaccin Immunother. 2018;14(12):2876–83. doi:10.1080/21645515.2018.1504523
   Google Scholar
• He Y, Liu Y, Dai B, Zhao L, Lin J, Yang J, Yu H. Assessing vaccination coverage, timeliness, and its temporal variations among children in arural area in China. Hum Vaccin Immunother. 2020;1–9. doi:10.1080/21645515.2020.1772620.
   Google Scholar
• Zhu F, Hu Y, Li J, Ye Q, Young MM, Liang JZ, Gruber WC, Giardina PC, Scott DA. Immunogenicity and Safety of the 13-Valent Pneumococcal Conjugate Vaccine Administered in a3 + 1 versus 2 + 1 Dose Schedule Among Infants in China. Pediatr Infect Dis J. 2019;38(11):1150–58. doi:10.1097/INF.0000000000002458.
   Google Scholar
• Rubin JL, McGarry LJ, Strutton DR, Klugman KP, Pelton SI, Gilmore KE, Weinstein MC. Public health and economic impact of the 13-valent pneumococcal conjugate vaccine (PCV13) in the United States. Vaccine. 2010;28(48):7634–43. doi:10.1016/j.vaccine.2010.09.049.
   Google Scholar
• Saokaew S, Rayanakorn WDB, Wu DBC, Chaiyakunapruk N. Cost Effectiveness of Pneumococcal Vaccination in Children in Low- and Middle-Income Countries: ASystematic Review. Pharm Econom. 2016;34(12):1211–25. doi:10.1007/s40273-016-0439-3.
   Google Scholar
• Chen C, Francisco CL, Stefan F, Sidharta S, Yoong J, SundaramN, JitM. Effect and cost-effectiveness of pneumococcal conjugate vaccination: aglobal modelling analysis. Lancet Global Health. 2019;7(1):e58–e67. doi:10.1016/S2214-109X(18)30422-4.
   Google Scholar
• Dilokthornsakul P, Kengkla K, Saokaew S, Permsuwan U, Techasaensiri C, Chotpitayasunondh T, Chaiyakunapruk N. An updated cost-effectiveness analysis of pneumococcal conjugate vaccine among children in Thailand. Vaccine. 2019;37(32):4551–60. doi:10.1016/j.vaccine.2019.06.015.
   Google Scholar
• Kobayashi M, Bigogo G, Kim L, Mogeni OD, Conklin LM, Odoyo A, Odiembo H, Pimenta F, Ouma D, Harris AM, etal. Impact of 10-Valent Pneumococcal Conjugate Vaccine Introduction on Pneumococcal Carriage and Antibiotic Susceptibility Patterns Among Children Aged <5 Years and Adults With Human Immunodeficiency Virus Infection: Kenya, 2009-2013. Clin Infect Dis. 2020:70(5):814-826. doi:10.1093/cid/ciz285.
   Google Scholar
• Chun-Yi L, Chuen-Sheue C, Cheng-Hsun C, Wang E-T, Chen -Y-Y, Yao S-M, Chang L-Y, Huang L-M, Lin T-Y, Chou J-H, etal. Successful Control of Streptococcus pneumoniae 19A Replacement With a Catch-up Primary Vaccination Program in Taiwan. Clin Infect Diseas. 2019;69(9):1581–87. doi:10.1093/cid/ciy1127.
   Google Scholar
• Troeger C, Blacker B, KhalilI A, Rao PC, Cao J, Zimsen SRM, Albertson SB, Deshpande A, Farag T, Abebe Z, etal. Estimates of the global, regional, and national morbidity, mortality, and etiologies of lower respiratory infections in 195 countries, 1990–2016: asystematic analysis for the Global Burden of Disease Study 2016. Lancet Infect Dis. 2018;18(11):1191–210. doi:10.1016/S1473-3099(18)30310-4.
   Google Scholar
• White Paper on Pneumonia and Vaccine Popularization in Chinese Children.
   Google Scholar
• Kwan KS, Oh IS, Kim HJ, Song I, Park MS, Shin J-Y. Signal detection of adverse events following pneumococcal vaccines from the Korea adverse event reporting system database, 2005–2016. Yonsei Med J. 2020;61(3):243–50. doi:10.3349/ymj.2020.61.3.243.
   Google Scholar
• Shiri T, Datta S, Madan J, Tsertsvadze A, Royle P, Keeling MJ, McCarthy ND, Petrou S. Indirect effects of childhood pneumococcal conjugate vaccination on invasive pneumococcal disease: asystematic review and meta-analysis. Lancet Global Health. 2017;5(1):e51–e59. doi:10.1016/S2214-109X(16)30306-0
   Google Scholar